Defective orthopedic mattresses and Medline beds have killed seven people in the US — EADaily, November 14th, 2026 — Accidents, USA
The FDA recalled Medline's medical beds and orthopedic mattresses after seven deaths and 35 injuries due to overheating and design flaws. The recall covers products sold in the US and Canada since 2011. The FDA advised users to disconnect beds and supervise patients.
How this was made

The 30-second read
Why it matters
The recall could lead to short-term sales disruption for Medline and heightened regulatory focus on similar products.
Market read
While no public stock is affected, the recall underscores regulatory risk for medical device firms and may influence investor sentiment in the sector.
What to watch
Potential liability claims and insurance cost increases for hospitals using the recalled products.
Background
The FDA announced a recall of Medline's orthopedic mattresses and medical beds after seven deaths and 35 serious injuries were reported.
Market effects
Highlights safety and compliance risks for medical device manufacturers.
May affect US and Canadian hospital procurement decisions.
Raises broader regulatory scrutiny on orthopedic equipment worldwide.
Counterpoint
Investors may view the recall as isolated to Medline and not indicative of sector-wide issues.
Key entities
- CompanyMedline
Private medical supplies manufacturer subject to FDA recall.
- RegulatorFDA
U.S. Food and Drug Administration issuing the recall.
